This inventor holds 1 USPTO granted patent. Top assignee: Hk Biotech Co., Ltd.. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Cherl Woo Park: Innovator in Isoflavone Research
Introduction
Cherl Woo Park is a notable inventor based in Gyeongsangnam-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of isoflavone-β-D-glucan. His work focuses on the production and application of this compound for health benefits.
Latest Patents
Cherl Woo Park holds 1 patent related to low and medium molecular weight isoflavone-β-D-glucan. This invention involves a method of producing isoflavone-β-D-glucan using autolysis enzymes from mycelia. The resulting compound is recognized for its potential anti-cancer and immunoenhancing effects.
Career Highlights
Cherl Woo Park is associated with Hk Biotech Co., Ltd., where he continues to advance his research. His innovative approach has positioned him as a key figure in the biotechnology sector, contributing to the understanding and utilization of isoflavones.
Collaborations
Cherl Woo Park collaborates with talented individuals such as Jeong Ok Kim and Yeong Lae Ha. Their combined expertise enhances the research and development efforts at Hk Biotech Co., Ltd.
Conclusion
Cherl Woo Park's work in the field of biotechnology, particularly with isoflavone-β-D-glucan, showcases his commitment to innovation and health improvement. His contributions are paving the way for future advancements in this area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile